224 related articles for article (PubMed ID: 23724051)
1. Spatiotemporal characterization of mTOR kinase activity following kainic acid induced status epilepticus and analysis of rat brain response to chronic rapamycin treatment.
Macias M; Blazejczyk M; Kazmierska P; Caban B; Skalecka A; Tarkowski B; Rodo A; Konopacki J; Jaworski J
PLoS One; 2013; 8(5):e64455. PubMed ID: 23724051
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin reveals an mTOR-independent repression of Kv1.1 expression during epileptogenesis.
Sosanya NM; Brager DH; Wolfe S; Niere F; Raab-Graham KF
Neurobiol Dis; 2015 Jan; 73():96-105. PubMed ID: 25270294
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin has paradoxical effects on S6 phosphorylation in rats with and without seizures.
Chen L; Hu L; Dong JY; Ye Q; Hua N; Wong M; Zeng LH
Epilepsia; 2012 Nov; 53(11):2026-33. PubMed ID: 23145776
[TBL] [Abstract][Full Text] [Related]
4. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy.
Zeng LH; Rensing NR; Wong M
J Neurosci; 2009 May; 29(21):6964-72. PubMed ID: 19474323
[TBL] [Abstract][Full Text] [Related]
5. Sequel of spontaneous seizures after kainic acid-induced status epilepticus and associated neuropathological changes in the subiculum and entorhinal cortex.
Drexel M; Preidt AP; Sperk G
Neuropharmacology; 2012 Oct; 63(5):806-17. PubMed ID: 22722023
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin reverses status epilepticus-induced memory deficits and dendritic damage.
Brewster AL; Lugo JN; Patil VV; Lee WL; Qian Y; Vanegas F; Anderson AE
PLoS One; 2013; 8(3):e57808. PubMed ID: 23536771
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of pentylenetrazole-induced acute status epilepticus in rats by adenosine involves inhibition of the mammalian target of rapamycin pathway.
Wang Y; Liu X; Wang Y; Chen J; Han T; Su L; Zang K
Neuroreport; 2017 Oct; 28(15):1016-1021. PubMed ID: 28902712
[TBL] [Abstract][Full Text] [Related]
8. The mTOR inhibitor rapamycin has limited acute anticonvulsant effects in mice.
Hartman AL; Santos P; Dolce A; Hardwick JM
PLoS One; 2012; 7(9):e45156. PubMed ID: 22984623
[TBL] [Abstract][Full Text] [Related]
9. c-Jun N-terminal kinase signaling pathway in excitotoxic cell death following kainic acid-induced status epilepticus.
Spigolon G; Veronesi C; Bonny C; Vercelli A
Eur J Neurosci; 2010 Apr; 31(7):1261-72. PubMed ID: 20345908
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of (immuno)proteasome subunits during epileptogenesis is attenuated by inhibition of the mammalian target of rapamycin pathway.
Broekaart DWM; van Scheppingen J; Geijtenbeek KW; Zuidberg MRJ; Anink JJ; Baayen JC; Mühlebner A; Aronica E; Gorter JA; van Vliet EA
Epilepsia; 2017 Aug; 58(8):1462-1472. PubMed ID: 28643873
[TBL] [Abstract][Full Text] [Related]
11. Mapping the spatio-temporal pattern of the mammalian target of rapamycin (mTOR) activation in temporal lobe epilepsy.
Sha LZ; Xing XL; Zhang D; Yao Y; Dou WC; Jin LR; Wu LW; Xu Q
PLoS One; 2012; 7(6):e39152. PubMed ID: 22761730
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation.
van Vliet EA; Forte G; Holtman L; den Burger JC; Sinjewel A; de Vries HE; Aronica E; Gorter JA
Epilepsia; 2012 Jul; 53(7):1254-63. PubMed ID: 22612226
[TBL] [Abstract][Full Text] [Related]
13. Prevention of post-ischemic seizure by rapamycin is associated with deactivation of mTOR and ERK1/2 pathways in hyperglycemic rats.
Yang X; Hei C; Liu P; Li PA
Biochem Biophys Res Commun; 2019 Nov; 520(1):47-53. PubMed ID: 31564412
[TBL] [Abstract][Full Text] [Related]
14. Akt Inhibitor Perifosine Prevents Epileptogenesis in a Rat Model of Temporal Lobe Epilepsy.
Zhu F; Kai J; Chen L; Wu M; Dong J; Wang Q; Zeng LH
Neurosci Bull; 2018 Apr; 34(2):283-290. PubMed ID: 28786074
[TBL] [Abstract][Full Text] [Related]
15. Impact of rapamycin on status epilepticus induced hippocampal pathology and weight gain.
Hester MS; Hosford BE; Santos VR; Singh SP; Rolle IJ; LaSarge CL; Liska JP; Garcia-Cairasco N; Danzer SC
Exp Neurol; 2016 Jun; 280():1-12. PubMed ID: 26995324
[TBL] [Abstract][Full Text] [Related]
16. Activation of mTOR signaling pathway is secondary to neuronal excitability in a mouse model of mesio-temporal lobe epilepsy.
Shima A; Nitta N; Suzuki F; Laharie AM; Nozaki K; Depaulis A
Eur J Neurosci; 2015 Apr; 41(7):976-88. PubMed ID: 25605420
[TBL] [Abstract][Full Text] [Related]
17. Targeting of microRNA-21-5p protects against seizure damage in a kainic acid-induced status epilepticus model via PTEN-mTOR.
Tang C; Gu Y; Wang H; Wu H; Wang Y; Meng Y; Han Z; Gu Y; Ma W; Jiang Z; Song Y; Na M; Lu D; Lin Z
Epilepsy Res; 2018 Aug; 144():34-42. PubMed ID: 29751355
[TBL] [Abstract][Full Text] [Related]
18. Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures.
Yang MT; Lin YC; Ho WH; Liu CL; Lee WT
J Neuroinflammation; 2017 Jan; 14(1):15. PubMed ID: 28109197
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic target of rapamycin (mTOR) signaling in status epilepticus.
Crino PB
Epilepsy Behav; 2019 Dec; 101(Pt B):106550. PubMed ID: 31732331
[TBL] [Abstract][Full Text] [Related]
20. Blood-brain barrier leakage after status epilepticus in rapamycin-treated rats I: Magnetic resonance imaging.
van Vliet EA; Otte WM; Wadman WJ; Aronica E; Kooij G; de Vries HE; Dijkhuizen RM; Gorter JA
Epilepsia; 2016 Jan; 57(1):59-69. PubMed ID: 26691904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
